The stock of BioRestorative Therapies Inc (NASDAQ: BRTX) has increased by 18.56 when compared to last closing price of 1.32.Despite this, the company has seen a gain of 22.27% in its stock price over the last five trading days. GlobeNewsWire reported 2024-02-01 that — Blinded data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in poster presentation — — Company to host webcasted conference call to review data on February 5, 2024 at 8:30am EST — MELVILLE, N.Y., Feb. 01, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc.
Is It Worth Investing in BioRestorative Therapies Inc (NASDAQ: BRTX) Right Now?
The 36-month beta value for BRTX is at 61.63. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BRTX is 4.90M, and currently, shorts hold a 0.83% of that float. The average trading volume for BRTX on April 16, 2024 was 477.84K shares.
BRTX’s Market Performance
BRTX’s stock has seen a 22.27% increase for the week, with a 17.67% rise in the past month and a -2.80% fall in the past quarter. The volatility ratio for the week is 5.60%, and the volatility levels for the past 30 days are at 5.97% for BioRestorative Therapies Inc The simple moving average for the past 20 days is 15.98% for BRTX’s stock, with a -21.00% simple moving average for the past 200 days.
BRTX Trading at 9.25% from the 50-Day Moving Average
After a stumble in the market that brought BRTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.05% of loss for the given period.
Volatility was left at 5.97%, however, over the last 30 days, the volatility rate increased by 5.60%, as shares surge +10.07% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -45.36% lower at present.
During the last 5 trading sessions, BRTX rose by +19.53%, which changed the moving average for the period of 200-days by -64.17% in comparison to the 20-day moving average, which settled at $1.3564. In addition, BioRestorative Therapies Inc saw -10.05% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BRTX starting from Silva Francisco, who purchase 6,600 shares at the price of $1.25 back on Apr 09 ’24. After this action, Silva Francisco now owns 155,759 shares of BioRestorative Therapies Inc, valued at $8,250 using the latest closing price.
Silva Francisco, the VP of Research and Development of BioRestorative Therapies Inc, purchase 1,708 shares at $1.16 during a trade that took place back on Apr 08 ’24, which means that Silva Francisco is holding 149,159 shares at $1,979 based on the most recent closing price.
Stock Fundamentals for BRTX
Current profitability levels for the company are sitting at:
- -104.39 for the present operating margin
- -0.53 for the gross margin
The net margin for BioRestorative Therapies Inc stands at -78.85. The total capital return value is set at -1.32. Equity return is now at value -105.30, with -99.26 for asset returns.
Based on BioRestorative Therapies Inc (BRTX), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -39.62. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 86.45.
Currently, EBITDA for the company is -15.06 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 69.34. The receivables turnover for the company is 7.55for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.71.
Conclusion
In conclusion, BioRestorative Therapies Inc (BRTX) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
